What is he best known for?
The fields of study he is best known for:
His scientific interests lie mostly in Biochemistry, Arachidonic acid, Cyclooxygenase, Prostaglandin and Pharmacology.
His Biochemistry study frequently draws connections between related disciplines such as Stereochemistry.
His research in Arachidonic acid intersects with topics in Oxygenation, Cell and Endocannabinoid system.
His Cyclooxygenase study also includes fields such as
- Inflammation which intersects with area such as Gene isoform,
- Enzyme inhibitor which intersects with area such as Chemical synthesis.
In his work, Prostacyclin synthase is strongly intertwined with Prostacyclin, which is a subfield of Prostaglandin.
His Pharmacology research includes themes of Cannabinoid receptor antagonist, Cancer, Molecular targets and In vivo.
His most cited work include:
- Oxyradicals and DNA damage (1541 citations)
- Identification and Functional Characterization of Brainstem Cannabinoid CB2 Receptors (1223 citations)
- Lipid peroxidation—DNA damage by malondialdehyde (904 citations)
What are the main themes of his work throughout his whole career to date?
Lawrence J. Marnett mainly investigates Biochemistry, Stereochemistry, Cyclooxygenase, Enzyme and Arachidonic acid.
His study in Molecular biology extends to Biochemistry with its themes.
His Cyclooxygenase research focuses on Pharmacology and how it relates to Cancer.
The various areas that Lawrence J. Marnett examines in his Arachidonic acid study include Lipoxygenase and Endocannabinoid system.
His Endocannabinoid system research incorporates elements of Anandamide, Cannabinoid receptor and Cannabinoid.
His DNA study integrates concerns from other disciplines, such as Adduct and Guanine.
He most often published in these fields:
- Biochemistry (40.27%)
- Stereochemistry (19.62%)
- Cyclooxygenase (17.85%)
What were the highlights of his more recent work (between 2013-2021)?
- Biochemistry (40.27%)
- Cyclooxygenase (17.85%)
- Enzyme (15.49%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Biochemistry, Cyclooxygenase, Enzyme, Cancer research and Endocannabinoid system.
His study in Prostaglandin, Metabolism, DNA, Electrophile and Lysine are all subfields of Biochemistry.
His research integrates issues of IC50, Arachidonic acid, Pharmacology and Cytotoxicity in his study of Cyclooxygenase.
His Enzyme study incorporates themes from Stereochemistry and Intracellular.
He interconnects Carcinogenesis, Cancer, Ovarian cancer, Cell culture and Pathology in the investigation of issues within Cancer research.
His Endocannabinoid system research is multidisciplinary, relying on both Anandamide, 2-Arachidonoylglycerol, Cannabinoid receptor and Neuroscience.
Between 2013 and 2021, his most popular works were:
- Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation (85 citations)
- Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. (78 citations)
- Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation (72 citations)
In his most recent research, the most cited papers focused on:
Lawrence J. Marnett focuses on Endocannabinoid system, Pharmacology, Cyclooxygenase, Biochemistry and Amygdala.
The Endocannabinoid system study combines topics in areas such as Anandamide, Fatty acid amide hydrolase and Anxiolytic.
The concepts of his Pharmacology study are interwoven with issues in Cannabinoid, Oxicam and Thiazine.
His Cyclooxygenase study necessitates a more in-depth grasp of Enzyme.
His works in Electrophile, Oxidative stress, Alkylation, Mutagenesis and G protein-coupled receptor are all subjects of inquiry into Biochemistry.
Lawrence J. Marnett studied Monoacylglycerol lipase and Arachidonic acid that intersect with Prostaglandin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
